Identification and autoregulation of receptor for OX-LDL in cultured human coronary artery endothelial cells
- PMID: 9703956
- DOI: 10.1006/bbrc.1998.9004
Identification and autoregulation of receptor for OX-LDL in cultured human coronary artery endothelial cells
Abstract
Although macrophages scavenge oxidatively modified low density lipoprotein (ox-LDL) via specific receptors, the uptake of ox-LDL by endothelial cells is thought to be mediated by a different receptor (LOX-1). We examined the presence of LOX-1 on cultured human coronary artery endothelial cells (HCAECs) by RT-PCR, radioligand blot, and binding assays. LOX-1 mRNA and protein were consistently identified in HCAECs. [125I]-ox-LDL binding assay also identified high affinity binding sites for LOX-1 on HCAECs (KD: 1.71 x 10(-8) M: Bmax: 29.7 ng/mg protein). There was no change in LOX-1 expression in HCAECs treated with native-LDL. In contrast, incubation of HCAECs with ox-LDL (10-40 micrograms/ml) increased LOX-1 expression (mRNA and protein). The upregulation of LOX-1 expression appeared to be dependent on ox-LDL concentration. Higher concentration (100 micrograms/ml) however, decreased LOX-1 expression, perhaps related to its cytotoxic effect. These observations indicate that ox-LDL upregulates its own receptor on HCAECs. This phenomenon may explain enhanced uptake of ox-LDL by HCAECs in hyperlipidemia resulting in cellular dysfunction.
Similar articles
-
Aspirin inhibits ox-LDL-mediated LOX-1 expression and metalloproteinase-1 in human coronary endothelial cells.Cardiovasc Res. 2004 Nov 1;64(2):243-9. doi: 10.1016/j.cardiores.2004.07.002. Cardiovasc Res. 2004. PMID: 15485683
-
Pioglitazone inhibits LOX-1 expression in human coronary artery endothelial cells by reducing intracellular superoxide radical generation.Arterioscler Thromb Vasc Biol. 2003 Dec;23(12):2203-8. doi: 10.1161/01.ATV.0000094411.98127.5F. Epub 2003 Sep 4. Arterioscler Thromb Vasc Biol. 2003. PMID: 12958047
-
Upregulation of endothelial receptor for oxidized low-density lipoprotein (LOX-1) in cultured human coronary artery endothelial cells by angiotensin II type 1 receptor activation.Circ Res. 1999 May 14;84(9):1043-9. doi: 10.1161/01.res.84.9.1043. Circ Res. 1999. PMID: 10325241
-
The role of LOX-1, a novel lectin-like receptor for oxidized low density lipoprotein, in atherosclerosis.Can J Cardiol. 2004 Aug;20 Suppl B:32B-36B. Can J Cardiol. 2004. PMID: 15309203 Review.
-
Oxidized LDL, LOX-1 and atherosclerosis.Cardiovasc Drugs Ther. 2011 Oct;25(5):419-29. doi: 10.1007/s10557-011-6341-5. Cardiovasc Drugs Ther. 2011. PMID: 21947818 Review.
Cited by
-
Azilsartan ameliorates ox-LDL-induced endothelial dysfunction via promoting the expression of KLF2.Aging (Albany NY). 2021 May 4;13(9):12996-13005. doi: 10.18632/aging.202973. Epub 2021 May 4. Aging (Albany NY). 2021. PMID: 33946046 Free PMC article.
-
LOX-1, OxLDL, and atherosclerosis.Mediators Inflamm. 2013;2013:152786. doi: 10.1155/2013/152786. Epub 2013 Jul 10. Mediators Inflamm. 2013. PMID: 23935243 Free PMC article. Review.
-
Regulation of foam cells by adenosine.Arterioscler Thromb Vasc Biol. 2012 Apr;32(4):879-86. doi: 10.1161/ATVBAHA.111.226878. Arterioscler Thromb Vasc Biol. 2012. PMID: 22423040 Free PMC article. Review.
-
The discovery of LOX-1, its ligands and clinical significance.Cardiovasc Drugs Ther. 2011 Oct;25(5):379-91. doi: 10.1007/s10557-011-6324-6. Cardiovasc Drugs Ther. 2011. PMID: 21805404 Free PMC article. Review.
-
A platelet-endothelium interaction mediated by lectin-like oxidized low-density lipoprotein receptor-1.Proc Natl Acad Sci U S A. 2000 Jan 4;97(1):360-4. doi: 10.1073/pnas.97.1.360. Proc Natl Acad Sci U S A. 2000. PMID: 10618423 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources